Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Global health

Unicef secures deal to buy pentavalent vaccine at half its current price

Shanelle Hall, director of Unicef's supply and procurement division

Source: John Zarocostas

Shanelle Hall, director of Unicef’s supply and procurement division, says Unicef now has the best access to the pentavalent vaccine since its launch 16 years ago

The United Nations Children’s Fund (Unicef) has secured a deal to purchase the pentavalent vaccine — a combination of five vaccines against diphtheria, tetanus, whooping cough, hepatitis B and Haemophilus influenza type b — at an average price of US$0.84, half what the agency pays now.

Unicef announced on 19 October 2016 that it had reached agreement with six suppliers to buy 450 million doses of the vaccine, a cornerstone of routine immunisation programmes. Most of the vaccines will be allocated to the 73 countries supported by the Gavi vaccine alliance, a public-private partnership committed to increasing access to vaccines.

Shanelle Hall, director of Unicef’s supply and procurement division, says: “Through lower prices and multiple supply base, we have the best access since [the pentavalent vaccine] was launched 16 years ago.”

She also notes that the new pricing agreement will generate over US$366m in savings for donors and governments.

The manufacturers that have agreed to supply the pentavalent vaccine at the reduced price are: Biologica E Limited (India); Janssen Vaccines Corporation (India); LG Life Science Limited (South Korea); Panacea Biotec Limited (India); Serum Institute of India; and Shantha Biotechnics (India).

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20201871

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Shanelle Hall, director of Unicef's supply and procurement division

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.